NICE guideline CG189 ( Obesity: identification, assessment and management ) and NICE public health guidance PH53 ( Weight management: lifestyle services for overweight or obese adults ) outline a stepped-care approach, which may include: Tier 2 community-based lifestyle and behavioural interventions Tier 3 specialist multidisciplinary weight management services Pharmacotherapy , where clinically appropriate for example, orlistat (subject to BNF/MHRA prescribing criteria and available via GP or specialist services) or semaglutide 2.4 mg (Wegovy), which is approved by NICE technology appraisal TA875 for use within specialist NHS weight management services for adults meeting defined BMI and comorbidity thresholds Bariatric surgery in selected cases, as outlined in NICE CG189 Pharmacotherapy for weight management should only be initiated and monitored in accordance with NICE, BNF, and MHRA guidance, and within appropriate clinical services
The bill is bipartisan, cosponsored by state Rep
This central mechanism is distinct from PDE5 inhibitors like sildenafil, which act peripherally on vascular smooth muscle
Technically, yesbut its considered off-label
Steven Batash, MD, is a gastroenterologist and leading physician at the Batash Endoscopic Weight Loss Center